Holdings of THE HARTFORD HEALTHCARE FUND
HARTFORD MUTUAL FUNDS, INC · Original filing · Compare with another fund · Report an error
- Net assets
- 729.2M $ including 717.7M $ in equities, 98.4 %
- Positions
- 82 in 8 countries
- Top ten
- 46.9 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 94,519 | 88.3M $ | 12.11 % |
| 2 | Merck & Co Inc | 421,010 | 46M $ | 6.30 % |
| 3 | Johnson & Johnson | 184,164 | 42.3M $ | 5.81 % |
| 4 | UnitedHealth Group Inc | 109,012 | 40.4M $ | 5.54 % |
| 5 | Intuitive Surgical Inc | 57,736 | 26.4M $ | 3.62 % |
| 6 | AbbVie Inc | 106,556 | 22.5M $ | 3.09 % |
| 7 | Abbott Laboratories | 224,493 | 20.4M $ | 2.80 % |
| 8 | Danaher Corp | 109,308 | 19.6M $ | 2.68 % |
| 9 | Edwards Lifesciences Corp | 222,047 | 18.5M $ | 2.54 % |
| 10 | CVS Health Corp | 213,326 | 17.8M $ | 2.44 % |
| 11 | Vertex Pharmaceuticals Inc | 40,946 | 17.5M $ | 2.40 % |
| 12 | Boston Scientific Corp | 293,259 | 16.9M $ | 2.32 % |
| 13 | Elevance Health Inc | 39,861 | 15M $ | 2.06 % |
| 14 | Cencora Inc | 48,572 | 15M $ | 2.05 % |
| 15 | Thermo Fisher Scientific Inc | 28,548 | 13.7M $ | 1.88 % |
| 16 | Regeneron Pharmaceuticals, Inc. | 19,182 | 13.6M $ | 1.86 % |
| 17 | HCA Healthcare Inc | 30,243 | 13.1M $ | 1.80 % |
| 18 | Biogen Inc | 51,492 | 9.7M $ | 1.34 % |
| 19 | GSK PLC | 360,879 | 9.5M $ | 1.30 % |
| 20 | Cardinal Health, Inc. | 47,856 | 9.2M $ | 1.27 % |
| 21 | Agilent Technologies Inc | 79,872 | 9.2M $ | 1.27 % |
| 22 | United Therapeutics Corp | 15,097 | 8.6M $ | 1.18 % |
| 23 | Medtronic PLC | 106,061 | 8.6M $ | 1.18 % |
| 24 | Stryker Corp | 26,981 | 8.5M $ | 1.17 % |
| 25 | Dexcom Inc | 123,198 | 7.3M $ | 1.01 % |
| 26 | Argenx SE | 8,404 | 6.6M $ | 0.90 % |
| 27 | STERIS PLC | 28,488 | 6.2M $ | 0.85 % |
| 28 | Incyte Corp | 61,927 | 5.9M $ | 0.81 % |
| 29 | Ionis Pharmaceuticals Inc | 78,893 | 5.9M $ | 0.81 % |
| 30 | UCB SA | 21,218 | 5.8M $ | 0.79 % |
| 31 | Alnylam Pharmaceuticals Inc | 18,140 | 5.6M $ | 0.77 % |
| 32 | Bristol-Myers Squibb Co | 88,181 | 5.3M $ | 0.73 % |
| 33 | Ascendis Pharma A/S | 22,837 | 5.2M $ | 0.72 % |
| 34 | Madrigal Pharmaceuticals Inc | 10,120 | 5.2M $ | 0.72 % |
| 35 | Elanco Animal Health Inc | 215,158 | 4.8M $ | 0.66 % |
| 36 | Encompass Health Corp | 47,796 | 4.8M $ | 0.66 % |
| 37 | Kailera Therapeutics Inc | 188,198 | 4.7M $ | 0.65 % |
| 38 | HeartFlow Inc | 147,880 | 4.4M $ | 0.60 % |
| 39 | Galderma Group AG | 20,401 | 4.3M $ | 0.59 % |
| 40 | Arcus Biosciences Inc | 160,316 | 4.1M $ | 0.56 % |
| 41 | Bio-Techne Corp | 73,067 | 4M $ | 0.55 % |
| 42 | Protagonist Therapeutics Inc | 40,688 | 4M $ | 0.55 % |
| 43 | Cytokinetics Inc | 62,319 | 4M $ | 0.55 % |
| 44 | ICON PLC | 33,670 | 4M $ | 0.55 % |
| 45 | Pharvaris NV | 123,487 | 3.8M $ | 0.53 % |
| 46 | Viridian Therapeutics Inc | 278,409 | 3.8M $ | 0.51 % |
| 47 | Avantor Inc | 461,799 | 3.7M $ | 0.51 % |
| 48 | Mirum Pharmaceuticals Inc | 37,970 | 3.7M $ | 0.51 % |
| 49 | Disc Medicine Inc | 55,907 | 3.7M $ | 0.51 % |
| 50 | Revolution Medicines Inc | 23,937 | 3.4M $ | 0.47 % |
| 51 | PTC Therapeutics Inc | 52,549 | 3.4M $ | 0.47 % |
| 52 | Scholar Rock Holding Corp | 69,874 | 3.3M $ | 0.45 % |
| 53 | GenFleet Therapeutics Shanghai Inc | 583,800 | 3.2M $ | 0.45 % |
| 54 | Kymera Therapeutics Inc | 38,652 | 3.1M $ | 0.43 % |
| 55 | Adaptive Biotechnologies Corp | 218,296 | 3.1M $ | 0.42 % |
| 56 | Dianthus Therapeutics Inc | 35,054 | 3.1M $ | 0.42 % |
| 57 | Acadia Healthcare Co Inc | 118,448 | 3.1M $ | 0.42 % |
| 58 | Alignment Healthcare Inc | 135,254 | 3M $ | 0.42 % |
| 59 | Immunocore Holdings PLC | 108,668 | 3M $ | 0.42 % |
| 60 | Celldex Therapeutics Inc | 92,052 | 3M $ | 0.42 % |
| 61 | Oculis Holding AG | 109,845 | 3M $ | 0.41 % |
| 62 | Structure Therapeutics Inc | 71,938 | 3M $ | 0.41 % |
| 63 | Apogee Therapeutics Inc | 35,692 | 3M $ | 0.41 % |
| 64 | Inspire Medical Systems Inc | 51,992 | 2.9M $ | 0.40 % |
| 65 | QIAGEN NV | 84,169 | 2.9M $ | 0.40 % |
| 66 | AstraZeneca PLC | 15,481 | 2.9M $ | 0.40 % |
| 67 | Option Care Health Inc | 142,663 | 2.9M $ | 0.40 % |
| 68 | Mineralys Therapeutics Inc | 101,748 | 2.7M $ | 0.37 % |
| 69 | Immunome Inc | 117,155 | 2.7M $ | 0.37 % |
| 70 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 317,981 | 2.7M $ | 0.36 % |
| 71 | Xenon Pharmaceuticals Inc | 47,284 | 2.6M $ | 0.36 % |
| 72 | Stoke Therapeutics Inc | 76,905 | 2.5M $ | 0.35 % |
| 73 | Trevi Therapeutics Inc | 180,509 | 2.5M $ | 0.34 % |
| 74 | Vaxcyte Inc | 42,970 | 2.5M $ | 0.34 % |
| 75 | Centene Corp | 44,870 | 2.4M $ | 0.33 % |
| 76 | Natera Inc | 11,683 | 2.4M $ | 0.33 % |
| 77 | Crinetics Pharmaceuticals Inc | 57,316 | 2.2M $ | 0.30 % |
| 78 | Bridgebio Pharma Inc | 24,004 | 1.7M $ | 0.23 % |
| 79 | Newamsterdam Pharma Co NV | 54,042 | 1.5M $ | 0.21 % |
| 80 | Nuvalent Inc | 14,306 | 1.4M $ | 0.20 % |
| 81 | CG oncology Inc | 13,705 | 914.7K $ | 0.13 % |
| 82 | Alamar Biosciences Inc | 9,100 | 227.9K $ | 0.03 % |
Sector breakdown
- Health care 78.4 %
- Unattributed 21.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 96.5 %
- GBP 1.3 %
- HKD 0.8 %
- EUR 0.8 %
- CHF 0.6 %
The quoted currency of each line, as declared.
Country breakdown
- United States 93.0 %
- United Kingdom 1.7 %
- Netherlands 1.7 %
- Switzerland 1.0 %
- Hong Kong SAR China 0.8 %
- Belgium 0.8 %
- Ireland 0.6 %
- Canada 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 70 | 667.8M $ | 93.05 % |
| 2 | United Kingdom | 2 | 12.4M $ | 1.72 % |
| 3 | Netherlands | 3 | 11.9M $ | 1.66 % |
| 4 | Switzerland | 2 | 7.3M $ | 1.02 % |
| 5 | Hong Kong SAR China | 2 | 5.9M $ | 0.82 % |
| 6 | Belgium | 1 | 5.8M $ | 0.81 % |
| 7 | Ireland | 1 | 4M $ | 0.56 % |
| 8 | Canada | 1 | 2.6M $ | 0.37 % |
Cite this page
Titelia. "Holdings of THE HARTFORD HEALTHCARE FUND". https://titelia.com/en/funds/S000003576